Although we suggested that HGF/MET signaling is activated in tumor cells in close proximity to infiltrated microglia, the efficacy of METi in established brain metastases/tumors remains to be proven particularly whether and to which extent METi affect normal homeostatic processes e.g. those crucial for neuron survival. This evidence concerns the gene MET and neoplasm.